BioNTech says Sobi's Oelkers will replace Sahin as its CEO

BNTX•2026-08-03

CEO succession planned for 2027

BioNTech said on Monday that Sobi's CEO Guido Oelkers will succeed Ugur Sahin as its chief executive from February 1, 2027 at latest.

Aug. 3 (Reuters) - BioNTech said on Monday that Sobi's CEO Guido Oelkers will succeed Ugur Sahin as its chief executive from February 1, 2027 at latest.

BioNTech says Sobi's Oelkers will replace Sahin as its CEO

CEO succession planned for 2027

Related News

Airlines, cruise operators gain as oil prices slide

Flotek wins 10-year PREPA support contract, sees $400 million revenue backlog

Zhihu schedules earnings call alongside quarterly, interim results release

Avista Q2 FY26 GAAP net income more than doubled to $35 million; GAAP EPS rises to $0.43

NESR schedules second-quarter 2026 earnings release and conference call